Immune Checkpoint Inhibitor Market Surges 2025-2035
Market Overview The Immune Checkpoint Inhibitor Market is exploding as a game-changer in oncology, harnessing the body’s own defenses to fight cancer like never before. These therapies—think PD-1, PD-L1, and CTLA-4 blockers—unleash T-cells to target tumors, offering hope where traditional chemo falls short. With cancer rates climbing globally, especially in aging populations, this market is … Read more